Literature DB >> 3633201

Modulating effects of monocytes and autologous serum on natural killer capacity in multiple myeloma patients.

M T Ventura, R Crollo, E Lasaracina.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3633201     DOI： 10.1007/BF00321076

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


× No keyword cloud information.
  6 in total

1.  Remission maintenance therapy for multiple myeloma.

Authors: 
Journal:  Arch Intern Med       Date:  1975-01

2.  Mechanism of cell-mediated cytotoxicity at the single cell level. I. Estimation of cytotoxic T lymphocyte frequency and relative lytic efficiency.

Authors:  E Grimm; B Bonavida
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

Review 3.  Natural cell-mediated immunity.

Authors:  R B Herberman; H T Holden
Journal:  Adv Cancer Res       Date:  1978       Impact factor: 6.242

4.  In vitro studies of lymphocytes from patients with plasma cell myeloma. I. Stimulation by mitogens and cytotoxic activities.

Authors:  H Mellstedt; G Holm
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

5.  Abolished in vitro antibody response in elderly: exclusive involvement of prostaglandin-induced T suppressor cells.

Authors:  J F Delfraissy; P Galanaud; C Wallon; J F Balavoine; J Dormont
Journal:  Clin Immunol Immunopathol       Date:  1982-09

6.  A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.

Authors:  B G Durie; S E Salmon
Journal:  Cancer       Date:  1975-09       Impact factor: 6.860
  6 in total
  1 in total

1.  Defects of natural killer cell activity in children with untreated acute lymphocytic leukemia.

Authors:  J Gabrilovac; M Boranić; B Kusić; D Batinić; L Rajić; A Tiefenbach
Journal:  Klin Wochenschr       Date:  1988-04-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.